Paul Tudor Jones Xencor Inc Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Xencor Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 34,894 shares of XNCR stock, worth $594,593. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,894
Previous 30,774
13.39%
Holding current value
$594,593
Previous $582,000
20.45%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding XNCR
# of Institutions
216Shares Held
72MCall Options Held
2.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY11.1MShares$189 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.14MShares$156 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.6MShares$129 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$90.8 Million4.65% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$67 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.02B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...